Pharvaris N.V.
PHVS
$35.14
$1.103.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -198.21M | -180.86M | -180.86M | -183.29M |
| Total Depreciation and Amortization | -- | 472.70K | 447.60K | 447.60K | 372.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 34.15M | 25.23M | 25.23M | 30.71M |
| Change in Net Operating Assets | -- | 9.05M | 7.55M | 7.55M | 3.87M |
| Cash from Operations | -- | -154.55M | -147.63M | -147.63M | -148.34M |
| Capital Expenditure | -- | -174.20K | -343.90K | -343.90K | -658.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -174.20K | -343.90K | -343.90K | -658.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -219.00K | -179.30K | -179.30K | -180.20K |
| Issuance of Common Stock | -- | 171.74M | 171.99M | 171.99M | 1.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -10.91M | -10.91M | -10.91M | -1.00K |
| Cash from Financing | -- | 187.78M | 188.06M | 188.06M | 1.59M |
| Foreign Exchange rate Adjustments | -- | -13.64M | -2.98M | -2.98M | -9.32M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 19.42M | 37.12M | 37.12M | -156.73M |